相关实验视频
Updated: Jan 13, 2026

06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
2.1K
痴呆症老年人的认知刺激:系统性审查
María Jiménez-Palomares1, Olga Montero-Barrero2, Elisa María Garrido-Ardila1
1ADOLOR Research Group, Department of Medical-Surgical Therapy, Medicine Faculty and Health Sciences, University of Extremadura, 06006 Badajoz, Spain.
Journal of clinical medicine
|October 29, 2025
概括
认知刺激显著改善了老年痴呆症患者的认知功能. 这种非药理学方法也有利于护理人员,因为它提高了他们的生活质量和与患者的关系.
科学领域:
- 老年学是指老年学的学科.
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
背景情况:
- 痴呆症会影响认知处理,目前还没有治疗方法.
- 药物和非药物治疗的目的是减缓痴呆症的进展.
- 认知刺激是一种日益增长的非药物学兴趣,用于保存能力.
研究的目的:
- 系统地审查认知刺激对老年痴呆症患者的影响.
- 分析认知刺激对认知功能和生活质量的影响.
主要方法:
- 对Pubmed,OTSeeker,ScienceDirect,Dialnet和Scopus的研究进行了系统审查.
- 包括受控试验,随机和非随机临床试验以及试点研究.
- 专注于老年痴呆症患者的干预措施,并与其他非药物治疗方法进行比较.
主要成果:
- 审查中包括了21项研究.
- 大多数研究表明,干预组的认知表现与对照组相比有所改善.
- 四项研究评估了护理人员,两项研究显示护理人员关系和生活质量有所改善.
结论:
- 认知刺激对老年痴呆症患者的认知功能产生积极影响.
- 该疗法为护理人员提供了好处,改善了他们与健康有关的生活质量和人际关系.
- 需要进一步的研究,特别是关于痴呆症患者的生活质量.
相关概念视频
Cognitive Development During Adulthood
768
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
768
Alzheimer's Disease: Treatment
806
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
806
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
544
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
544
Dementia
511
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
511

